NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes
The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR and impedance.
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Official Title:||NIR (Near Infrared)- Spectroscopy and Multifrequent Impedance Spectroscopy on the Skin to Detection of Sensory and Autonomic Neuropathy Among Patients With Type 1 Diabetes|
- near infrared spectroscopy [ Time Frame: one time ] [ Designated as safety issue: No ]Near infrared (NIR) is measured by spectroscopy on the skin using the DDD probe
|Study Start Date:||September 2012|
|Study Completion Date:||October 2012|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|
Male participants, type1 diabetic with diabetic neuropathy
Diabetes without neuropathy
Male participants, type1 diabetic without diabetic neuropathy
Non diabetic control
Male participants, control group non diabetic
The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe) using NIR (near infrared light) as well as impedance (conductivity), is to detect early signs of diabetic neuropathy.
The DDD-probe is put directly on the skin and is measuring by the use of light and impedance.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01707979
|Steno Diabetes Center|
|Gentofte, Denmark, 2820|
|Principal Investigator:||Lise Tarnow, Professor||Steno Diabetes Center|